GSK

What's in the Cards for Glaxo (GSK) This Earnings Season?
What's in the Cards for Glaxo (GSK) This Earnings Season?
Yahoo/Zacks.com
GSK
earnings
Flag link:
Good news, Glaxo: Novartis' Advair copy definitely won't see the market this year
Good news, Glaxo: Novartis' Advair copy definitely won't see the market this year
Fierce Pharma
Novartis
GSK
Advair
asthma
Flag link:
Q1 kicks off with J&J, Novartis, Glaxo results
Q1 kicks off with J&J, Novartis, Glaxo results
Biopharma Dive
earnings
JNJ
Novartis
GSK
Flag link:
GSK slims portfolio with sale of rare disease gene therapy drugs
GSK slims portfolio with sale of rare disease gene therapy drugs
Yahoo/Reuters
GSK
Orchard Therapeutics
gene therapy
Rare Diseases
Flag link:
Study: Stop-smoking drugs Chantix, Zyban pose no heart risks
Study: Stop-smoking drugs Chantix, Zyban pose no heart risks
Stat
smoking cessation
Chantix
Zyban
Pfizer
GSK
Flag link:
Teva wins reversal of U.S. jury's $235 million GSK drug patent verdict
Teva wins reversal of U.S. jury's $235 million GSK drug patent verdict
Reuters
Teva Pharmaceutical
GSK
patents
Coreg
Flag link:
GSK buys out Novartis in $13 billion consumer healthcare shake-up
GSK buys out Novartis in $13 billion consumer healthcare shake-up
Yahoo/Reuters
GSK
Novartis
consumer healthcare
M&A
Flag link:
First assessment of radical reorganization imposed by GSK new CEO Emma Walmsley
First assessment of radical reorganization imposed by GSK new CEO Emma Walmsley
GoinPharma
GSK
Emma Walmsley
restructuring
Flag link:
Is Pfizer's Best Option Now a Consumer Healthcare Spinoff?
Is Pfizer's Best Option Now a Consumer Healthcare Spinoff?
Motley Fool
Pfizer
consumer health
spinoffs
GSK
Flag link:
GSK pulls out of $20 billion race for Pfizer consumer assets
GSK pulls out of $20 billion race for Pfizer consumer assets
CNBC
GSK
Pfizer
M&A
consumer health
Flag link:
GSK's two-drug HIV regimen wins European panel approval
GSK's two-drug HIV regimen wins European panel approval
Reuters
GSK
HIV
Europe
CHMP
Juluca
Flag link:
Glaxo's Boss Looks Ready to Loosen the Straitjacket
Glaxo's Boss Looks Ready to Loosen the Straitjacket
Bloomberg
GSK
Emma Walmsley
Pharma CEOs
consumer health
Pfizer
M&A
Flag link:
GSK trials Benlysta/rituximab combo for lupus
GSK trials Benlysta/rituximab combo for lupus
Pharma Times
GSK
clinical trials
Benlysta
rituximab
lupus
Flag link:
12 blockbusters: The surging list of $1B-plus drugs rolling out on the market this year might surprise you
12 blockbusters: The surging list of $1B-plus drugs rolling out on the market this year might surprise you
Endpoints
drug launches
Hemlibra
Roche
Biktarvy
Gilead Sciences
Ozempic
Novo Nordisk
Erleada
JNJ
Shingrix
GSK
Patisiran
Alnylam
Sanofi
Epidiolex
GW Pharma
Aimovig
Amgen
Novartis
lanadelumab
Shire
Elagolix
AbbVie
Steglatro
Pfizer
Merck
Sublocade
Indivior
Flag link:
GSK's bid in focus as Reckitt quits Pfizer consumer health auction
GSK's bid in focus as Reckitt quits Pfizer consumer health auction
Yahoo/Reuters
GSK
Pfizer
consumer health
M&A
Reckitt Benckiser
Flag link:
GlaxoSmithKline prescribes commercial reboot for pharma division
GlaxoSmithKline prescribes commercial reboot for pharma division
Yahoo/Reuters
GSK
restructuring
Luke Miels
R&D
Flag link:
China's Aim to Remove Cancer Drug Taxes May Boost Pfizer, Glaxo
China's Aim to Remove Cancer Drug Taxes May Boost Pfizer, Glaxo
Bloomberg
China
Pfizer
GSK
cancer
taxes
Flag link:
GlaxoSmithKline scores retail deal with CVS, spreading Shingrix to thousands of pharmacies
GlaxoSmithKline scores retail deal with CVS, spreading Shingrix to thousands of pharmacies
Fierce Pharma
GSK
vaccines
Shingrix
shingles
CVS
Flag link:
Glaxo Sees Up to $100 Million in Initial Costs From Brexit
Glaxo Sees Up to $100 Million in Initial Costs From Brexit
Bloomberg
GSK
Brexit
Flag link:
Big Pharma's winners and losers last year? AbbVie and AstraZeneca up, GSK down
Big Pharma's winners and losers last year? AbbVie and AstraZeneca up, GSK down
Fierce Pharma
AbbVie
AstraZeneca
GSK
Sanofi
Merck
Big Pharma
Flag link:

Pages